Fatalities in opioid agonist treatment with long-acting injectable buprenorphine
LAI BUP comprised 56% of OAT medication among all deceased OAT patients in 2020. Despite its recognized benefits, LAI BUP treatment was associated with deaths. Psychosocial support among the deceased LAI BUP patients seemed inadequate.
Authors
- Margareeta Häkkinen (ORCID: https://orcid.org/0000-0001-6637-9103)
- Claudia Mariottini (ORCID: https://orcid.org/0000-0002-6744-7689)
- Pirkko Kriikku (ORCID: https://orcid.org/0000-0002-5721-2827)
- Ilkka Ojanperä (ORCID: https://orcid.org/0000-0001-5790-1473)
Institutions
- University of Helsinki (FI)
- University of Turku (FI)
- Finnish Institute for Health and Welfare (FI)
Publication Details
- Journal
- International Journal of Legal Medicine
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1007/s00414-025-03535-w
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.88